To determine the role of CD4+Foxp3+ Tregs in the A33+ Li-EV-mediated decrease in severity of murine IBD, CD4+Foxp3+ Tregs were depleted by the pretreatment of mice with anti-CD25 monoclonal antibodies. This evidence concerns the gene CD4 and inflammatory bowel disease.